Hypothalamic–pituitary hormones during critical illness

Acker, 2000, A trial of thyroxine in acute renal failure, Kidney Int, 57, 293, 10.1046/j.1523-1755.2000.00827.x Angele, 1998, Testosterone: the culprit for producing splenocyte immune depression after trauma hemorrhage, Am J Physiol, 274, C1530, 10.1152/ajpcell.1998.274.6.C1530 Annane, 2000, A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin, JAMA, 283, 1038, 10.1001/jama.283.8.1038 Annane, 2002, Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock, JAMA, 288, 862, 10.1001/jama.288.7.862 Arnold, 1993, Increased whole body protein breakdown predominates over increased whole body protein synthesis in multiple organ failure, Clin Sci (Lond), 84, 655, 10.1042/cs0840655 Baricevic, 2007, Differential influence of open surgery and sepsis on the circulating insulin-like growth factors and their binding proteins as representative metabolic markers, Clin Biochem, 40, 1122, 10.1016/j.clinbiochem.2007.06.008 Barquist, 1997, Adrenal insufficiency in the surgical intensive care unit patient, J Trauma, 42, 27, 10.1097/00005373-199701000-00006 Baxter, 2001, Changes in the IGF-IGFBP axis in critical illness, Best Pract Res Clin Endocrinol Metab, 15, 421, 10.1053/beem.2001.0161 Baxter, 1989, Structure of the Mr 140,000 growth hormone-dependent insulin-like growth factor binding protein complex: determination by reconstitution and affinity-labeling, Proc Natl Acad Sci U S A, 86, 6898, 10.1073/pnas.86.18.6898 Baxter, 1998, Thirty-day monitoring of insulin-like growth factors and their binding proteins in intensive care unit patients, Growth Horm IGF Res, 8, 455, 10.1016/S1096-6374(98)80298-0 Beishuizen, 2001, Patterns of corticosteroid-binding globulin and the free cortisol index during septic shock and multitrauma, Intensive Care Med, 27, 1584, 10.1007/s001340101073 Benedict, 1978, Plasma noradrenaline and adrenaline concentrations and dopamine-beta-hydroxylase activity in patients with shock due to septicaemia, trauma and haemorrhage, Q J Med, 47, 1 Ben-Jonathan, 2001, Dopamine as a prolactin (PRL) inhibitor, Endocr Rev, 22, 724, 10.1210/edrv.22.6.0451 Bettendorf, 2000, Tri-iodothyronine treatment in children after cardiac surgery: a double-blind, randomised, placebo-controlled study, Lancet, 356, 529, 10.1016/S0140-6736(00)02576-9 Bianco, 2002, Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases, Endocr Rev, 23, 38, 10.1210/edrv.23.1.0455 Bodenner, 1991, A detailed functional and structural analysis of a major thyroid hormone inhibitory element in the human thyrotropin beta-subunit gene, J Biol Chem, 266, 21666, 10.1016/S0021-9258(18)54688-3 Boelen, 1995, The role of cytokines in the lipopolysaccharide-induced sick euthyroid syndrome in mice, J Endocrinol, 146, 475, 10.1677/joe.0.1460475 Boelen, 2008, Fasting-induced changes in the hypothalamus–pituitary–thyroid axis, Thyroid, 18, 123, 10.1089/thy.2007.0253 Boonen, 2013, Reduced cortisol metabolism during critical illness, N Engl J Med, 368, 1477, 10.1056/NEJMoa1214969 Bornstein, 1999, Clinical review 104: adrenocorticotropin (ACTH)- and non-ACTH-mediated regulation of the adrenal cortex: neural and immune inputs, J Clin Endocrinol Metab, 84, 1729, 10.1210/jcem.84.5.5631 Bornstein, 2008, Dissociation of ACTH and glucocorticoids, Trends Endocrinol Metab, 19, 175, 10.1016/j.tem.2008.01.009 Brent, 1986, Thyroxine therapy in patients with severe nonthyroidal illnesses and low serum thyroxine concentration, J Clin Endocrinol Metab, 63, 1, 10.1210/jcem-63-1-1 Burchard, 2001, A review of the adrenal cortex and severe inflammation: quest of the “eucorticoid” state, J Trauma, 51, 800, 10.1097/00005373-200110000-00033 Christeff, 1988, Elevated oestrogen and reduced testosterone levels in the serum of male septic shock patients, J Steroid Biochem, 29, 435, 10.1016/0022-4731(88)90254-3 Cooper, 2003, Corticosteroid insufficiency in acutely ill patients, N Engl J Med, 348, 727, 10.1056/NEJMra020529 De Groot, 1999, Dangerous dogmas in medicine: the nonthyroidal illness syndrome, J Clin Endocrinol Metab, 84, 151, 10.1210/jcem.84.1.5364 Debaveye, 2005, Tissue deiodinase activity during prolonged critical illness: effects of exogenous thyrotropin-releasing hormone and its combination with growth hormone-releasing peptide-2, Endocrinology, 146, 5604, 10.1210/en.2005-0963 Defalque, 1999, GH insensitivity induced by endotoxin injection is associated with decreased liver GH receptors, Am J Physiol, 276, E565 Devins, 1992, Effects of dopamine on T-lymphocyte proliferative responses and serum prolactin concentrations in critically ill patients, Crit Care Med, 20, 1644, 10.1097/00003246-199212000-00007 Dong, 1992, Circulating immunoreactive inhibin and testosterone levels in men with critical illness, Clin Endocrinol (Oxf), 36, 399, 10.1111/j.1365-2265.1992.tb01466.x Dossett, 2008, High levels of endogenous estrogens are associated with death in the critically injured adult, J Trauma, 64, 580, 10.1097/TA.0b013e31816543dd Duska, 2008, Frequent intravenous pulses of growth hormone together with glutamine supplementation in prolonged critical illness after multiple trauma: effects on nitrogen balance, insulin resistance, and substrate oxidation, Crit Care Med, 36, 1707, 10.1097/CCM.0b013e318174d499 Faglia, 1973, Reduced plasma thyrotropin response to thyrotropin releasing hormone after dexamethasone administration in normal subjects, Horm Metab Res, 5, 289, 10.1055/s-0028-1093930 Felmet, 2005, Prolonged lymphopenia, lymphoid depletion, and hypoprolactinemia in children with nosocomial sepsis and multiple organ failure, J Immunol, 174, 3765, 10.4049/jimmunol.174.6.3765 Ferrando, 2001, Testosterone administration in severe burns ameliorates muscle catabolism, Crit Care Med, 29, 1936, 10.1097/00003246-200110000-00015 Finlay, 1982, Serum cortisol levels in severely stressed patients, Lancet, 1, 1414, 10.1016/S0140-6736(82)92531-4 Fliers, 1997, Decreased hypothalamic thyrotropin-releasing hormone gene expression in patients with nonthyroidal illness, J Clin Endocrinol Metab, 82, 4032 Fourrier, 1994, Sex steroid hormones in circulatory shock, sepsis syndrome, and septic shock, Circ Shock, 43, 171 Freeman, 2000, Prolactin: structure, function, and regulation of secretion, Physiol Rev, 80, 1523, 10.1152/physrev.2000.80.4.1523 Friesema, 2005, Thyroid hormone transporters, Biochem Soc Trans, 33, 228, 10.1042/BST0330228 Fruchtman, 2000, Insulin-like growth factor I disparately regulates prolactin and growth hormone synthesis and secretion: studies using the teleost pituitary model, Endocrinology, 141, 2886, 10.1210/endo.141.8.7616 Gardner, 1979, Effect of tri-iodothyronine replacement on the metabolic and pituitary responses to starvation, N Engl J Med, 300, 579, 10.1056/NEJM197903153001102 Gilliver, 2010, Sex steroids as inflammatory regulators, J Steroid Biochem Mol Biol, 120, 105, 10.1016/j.jsbmb.2009.12.015 Goldsmith, 1951, The effect of thyrotropin on the release of hormone from the human thyroid, J Clin Endocrinol Metab, 11, 1079, 10.1210/jcem-11-10-1079 Guo, 1990, Interleukin-2 is a potent inhibitor of Leydig cell steroidogenesis, Endocrinology, 127, 1234, 10.1210/endo-127-3-1234 Hammond, 1990, A role for corticosteroid-binding globulin in delivery of cortisol to activated neutrophils, J Clin Endocrinol Metab, 71, 34, 10.1210/jcem-71-1-34 Hamrahian, 2004, Measurements of serum free cortisol in critically ill patients, N Engl J Med, 350, 1629, 10.1056/NEJMoa020266 Hermansson, 1997, Measurement of human growth hormone receptor messenger ribonucleic acid by a quantitative polymerase chain reaction-based assay: demonstration of reduced expression after elective surgery, J Clin Endocrinol Metab, 82, 421 Herndon, 1990, Effects of recombinant human growth hormone on donor-site healing in severely burned children, Ann Surg, 212, 424, 10.1097/00000658-199010000-00005 Hill, 2012, Ghrelin, appetite and critical illness, Curr Opin Crit Care, 18, 199, 10.1097/MCC.0b013e3283514b01 Howard, 1996, A receptor in pituitary and hypothalamus that functions in growth hormone release, Science, 273, 974, 10.1126/science.273.5277.974 Juneja, 1991, Diurnal variations and temporal coupling of bioactive and immunoactive luteinizing hormone, prolactin, testosterone and 17-beta-estradiol in adult men, Horm Res, 35, 89, 10.1159/000181880 Kageyama, 2009, Role and action in the pituitary corticotroph of corticotropin-releasing factor (CRF) in the hypothalamus, Peptides, 30, 810, 10.1016/j.peptides.2008.12.007 Kojima, 1999, Ghrelin is a growth-hormone-releasing acylated peptide from stomach, Nature, 402, 656, 10.1038/45230 Kupfer, 1993, Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously, J Clin Invest, 91, 391, 10.1172/JCI116212 Lamberts, 1990, Regulation of prolactin secretion at the level of the lactotroph, Physiol Rev, 70, 279, 10.1152/physrev.1990.70.2.279 Lim, 1993, Inhibition of thyroxine transport into cultured rat hepatocytes by serum of nonuremic critically ill patients: effects of bilirubin and nonesterified fatty acids, J Clin Endocrinol Metab, 76, 1165 Maldonado, 1992, Do thyroid function tests independently predict survival in the critically ill?, Thyroid, 2, 119, 10.1089/thy.1992.2.119 Marik, 2002, Adrenal insufficiency in the critically ill: a new look at an old problem, Chest, 122, 1784, 10.1378/chest.122.5.1784 Mebis, 2011, Thyroid axis function and dysfunction in critical illness, Best Pract Res Clin Endocrinol Metab, 25, 745, 10.1016/j.beem.2011.03.002 Mebis, 2007, The type II iodothyronine deiodinase is up-regulated in skeletal muscle during prolonged critical illness, J Clin Endocrinol Metab, 92, 3330, 10.1210/jc.2007-0510 Mebis, 2009, Changes in the central component of the hypothalamus–pituitary–thyroid axis in a rabbit model of prolonged critical illness, Crit Care, 13, R147, 10.1186/cc8043 Mebis, 2009, Expression of thyroid hormone transporters during critcal illness, Eur J Endocrinol, 161, 243, 10.1530/EJE-09-0290 Mebis, 2012, Contribution of nutritional deficit to the pathogenesis of the nonthyroidal illness syndrome in critical illness: a rabbit model study, Endocrinology, 153, 973, 10.1210/en.2011-1411 Mesotten, 2006, Changes within the GH/IGF-I/IGFBP axis in critical illness, Crit Care Clin, 22, 17, 10.1016/j.ccc.2005.09.002 Mesotten, 2004, Regulation of the somatotropic axis by intensive insulin therapy during protracted critical illness, J Clin Endocrinol Metab, 89, 3105, 10.1210/jc.2003-032102 Michalaki, 2001, Dissociation of the early decline in serum T(3) concentration and serum IL-6 rise and TNFalpha in nonthyroidal illness syndrome induced by abdominal surgery, J Clin Endocrinol Metab, 86, 4198 Minneci, 2004, Meta-analysis: the effect of steroids on survival and shock during sepsis depends on the dose, Ann Intern Med, 141, 47, 10.7326/0003-4819-141-1-200407060-00014 Nematy, 2006, Changes in appetite related gut hormones in intensive care unit patients: a pilot cohort study, Crit Care, 10, R10, 10.1186/cc3957 Noel, 1972, Human prolactin and growth hormone release during surgery and other conditions of stress, J Clin Endocrinol Metab, 35, 840, 10.1210/jcem-35-6-840 Ohlsson, 2009, The role of liver-derived insulin-like growth factor-I, Endocr Rev, 30, 494, 10.1210/er.2009-0010 Oudemans-van Straaten, 2001, Plasma glutamine depletion and patient outcome in acute ICU admissions, Intensive Care Med, 27, 84, 10.1007/s001340000703 Peeters, 2003, Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients, J Clin Endocrinol Metab, 88, 3202, 10.1210/jc.2002-022013 Peeters, 2005, Serum rT3 and T3/rT3 are prognostic markers in critically ill patients and are associated with post-mortem tissue deiodinase activities, J Clin Endocrinol Metab, 90, 4559, 10.1210/jc.2005-0535 Pemberton, 1988, Hormone binding globulins undergo serpin conformational change in inflammation, Nature, 336, 257, 10.1038/336257a0 Persani, 1995, Circadian variations of thyrotropin bioactivity in normal subjects and patients with primary hypothyroidism, J Clin Endocrinol Metab, 80, 2722 Plymate, 1987, Central hypogonadism in burned men, Horm Res, 27, 152, 10.1159/000180803 Popovic, 2003, Ghrelin main action on the regulation of growth hormone release is exerted at hypothalamic level, J Clin Endocrinol Metab, 88, 3450, 10.1210/jc.2003-030211 Popovic, 2005, Low plasma ghrelin level in gastrectomized patients is accompanied by enhanced sensitivity to the ghrelin-induced growth hormone release, J Clin Endocrinol Metab, 90, 2187, 10.1210/jc.2004-1888 Ray, 2002, Endocrine measurements in survivors and non-survivors from critical illness, Intensive Care Med, 28, 1301, 10.1007/s00134-002-1427-y Reis, 1998, Plasma prolactin and glucose alterations induced by surgical stress: a single or dual response?, Exp Physiol, 83, 1, 10.1113/expphysiol.1998.sp004086 Roberts, 2004, Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial, Lancet, 364, 1321, 10.1016/S0140-6736(04)17188-2 Rodas, 2012, Glutamine and glutathione at ICU admission in relation to outcome, Clin Sci (Lond), 122, 591, 10.1042/CS20110520 Rodriguez-Perez, 2008, Identification of molecular mechanisms related to nonthyroidal illness syndrome in skeletal muscle and adipose tissue from patients with septic shock, Clin Endocrinol (Oxf), 68, 821, 10.1111/j.1365-2265.2007.03102.x Romijn, 1990, Decreased nocturnal surge of thyrotropin in nonthyroidal illness, J Clin Endocrinol Metab, 70, 35, 10.1210/jcem-70-1-35 Ross, 1991, Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin-like growth factor-I, Clin Endocrinol (Oxf), 35, 47, 10.1111/j.1365-2265.1991.tb03495.x Rothwell, 1995, Prediction of outcome in intensive care patients using endocrine parameters, Crit Care Med, 23, 78, 10.1097/00003246-199501000-00015 Rothwell, 1991, Cortisol response to corticotropin and survival in septic shock, Lancet, 337, 582, 10.1016/0140-6736(91)91641-7 Rothwell, 1993, Thyrotropin concentration predicts outcome in critical illness, Anaesthesia, 48, 373, 10.1111/j.1365-2044.1993.tb07006.x Russell, 1989, New aspects of prolactin and immunity: a lymphocyte-derived prolactin-like product and nuclear protein kinase C activation, Trends Pharmacol Sci, 10, 40, 10.1016/0165-6147(89)90106-5 Sam, 2004, Cortisol levels and mortality in severe sepsis, Clin Endocrinol (Oxf), 60, 29, 10.1111/j.1365-2265.2004.01923.x Schlienger, 1991, Evaluation of thyroid function after myocardial infarction, Ann Endocrinol (Paris), 52, 283 Schuetz, 2009, Circulating levels of GH predict mortality and complement prognostic scores in critically ill medical patients, Eur J Endocrinol, 160, 157, 10.1530/EJE-08-0786 Semple, 1987, Mechanisms leading to hypogonadism in men with burns injuries, Br Med J (Clin Res Ed), 295, 403, 10.1136/bmj.295.6595.403 Span, 1992, Adrenocortical function: an indicator of severity of disease and survival in chronic critically ill patients, Intensive Care Med, 18, 93, 10.1007/BF01705039 Spratt, 1993, Reproductive axis suppression in acute illness is related to disease severity, J Clin Endocrinol Metab, 76, 1548 Spratt, 1993, Differential changes in serum concentrations of androgens and estrogens (in relation with cortisol) in postmenopausal women with acute illness, J Clin Endocrinol Metab, 76, 1542 Spratt, 2006, Increases in serum estrogen levels during major illness are caused by increased peripheral aromatization, Am J Physiol Endocrinol Metab, 291, E631, 10.1152/ajpendo.00467.2005 Sprung, 2008, Hydrocortisone therapy for patients with septic shock, N Engl J Med, 358, 111, 10.1056/NEJMoa071366 Stefaneanu, 1999, Somatotroph and lactotroph changes in the adenohypophyses of mice with disrupted insulin-like growth factor I gene, Endocrinology, 140, 3881, 10.1210/endo.140.9.6973 Takala, 1999, Increased mortality associated with growth hormone treatment in critically ill adults, N Engl J Med, 341, 785, 10.1056/NEJM199909093411102 Tannenbaum, 1984, The interrelationship of growth hormone (GH)-releasing factor and somatostatin in generation of the ultradian rhythm of GH secretion, Endocrinology, 115, 1952, 10.1210/endo-115-5-1952 Tannenbaum, 2003, Interrelationship between the novel peptide ghrelin and somatostatin/growth hormone-releasing hormone in regulation of pulsatile growth hormone secretion, Endocrinology, 144, 967, 10.1210/en.2002-220852 Thijssen-Timmer, 2007, Thyroid hormone receptor isoform expression in livers of critically ill patients, Thyroid, 17, 105, 10.1089/thy.2006.0164 Timmins, 1996, Critical illness is associated with low circulating concentrations of insulin-like growth factors-I and -II, alterations in insulin-like growth factor binding proteins, and induction of an insulin-like growth factor binding protein 3 protease, Crit Care Med, 24, 1460, 10.1097/00003246-199609000-00006 Vale, 1973, TRF and thyroid hormones on prolactin secretion by rat anterior pituitary cells in vitro, Endocrinology, 93, 26, 10.1210/endo-93-1-26 Van den Berghe, 2000, Novel insights into the neuroendocrinology of critical illness, Eur J Endocrinol, 143, 1, 10.1530/eje.0.1430001 Van den Berghe, 1994, Dopamine and the sick euthyroid syndrome in critical illness, Clin Endocrinol (Oxf), 41, 731, 10.1111/j.1365-2265.1994.tb02787.x Van den Berghe, 1994, Luteinizing hormone secretion and hypoandrogenaemia in critically ill men: effect of dopamine, Clin Endocrinol (Oxf), 41, 563, 10.1111/j.1365-2265.1994.tb01819.x Van den Berghe, 1996, Thyrotropin-releasing hormone in critical illness: from a dopamine-dependent test to a strategy for increasing low serum triiodothyronine, prolactin, and growth hormone concentrations, Crit Care Med, 24, 590, 10.1097/00003246-199604000-00007 Van den Berghe, 1996, Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotrophin-releasing hormone in critical illness, Clin Endocrinol (Oxf), 45, 341, 10.1046/j.1365-2265.1996.00805.x Van den Berghe, 1997, The somatotropic axis in critical illness: effect of continuous growth hormone (GH)-releasing hormone and GH-releasing peptide-2 infusion, J Clin Endocrinol Metab, 82, 590 Van den Berghe, 1997, Thyrotrophin and prolactin release in prolonged critical illness: dynamics of spontaneous secretion and effects of growth hormone-secretagogues, Clin Endocrinol (Oxf), 47, 599, 10.1046/j.1365-2265.1997.3371118.x Van den Berghe, 1998, Neuroendocrinology of prolonged critical illness: effects of exogenous thyrotropin-releasing hormone and its combination with growth hormone secretagogues, J Clin Endocrinol Metab, 83, 309 Van den Berghe, 1998, Clinical review 95: acute and prolonged critical illness as different neuroendocrine paradigms, J Clin Endocrinol Metab, 83, 1827 Van den Berghe, 1999, Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness, J Clin Endocrinol Metab, 84, 1311 Van den Berghe, 2000, A paradoxical gender dissociation within the growth hormone/insulin-like growth factor I axis during protracted critical illness, J Clin Endocrinol Metab, 85, 183 Van den Berghe, 2001, Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic–pituitary–gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness, J Clin Endocrinol Metab, 86, 3217 Van den Berghe, 2001, Intensive insulin therapy in critically ill patients, N Engl J Med, 345, 1359, 10.1056/NEJMoa011300 Van den Berghe, 2002, The combined administration of GH-releasing peptide-2 (GHRP-2), TRH and GnRH to men with prolonged critical illness evokes superior endocrine and metabolic effects compared to treatment with GHRP-2 alone, Clin Endocrinol (Oxf), 56, 655, 10.1046/j.1365-2265.2002.01255.x Van der Poll, 1990, Tumor necrosis factor: a putative mediator of the sick euthyroid syndrome in man, J Clin Endocrinol Metab, 71, 1567, 10.1210/jcem-71-6-1567 Van der Poll, 1995, Interleukin-1 receptor blockade does not affect endotoxin-induced changes in plasma thyroid hormone and thyrotropin concentrations in man, J Clin Endocrinol Metab, 80, 1341 Van der Poll, 1999, Neutralization of TNF does not influence endotoxininduced changes in thyroid hormone metabolism in humans, Am J Physiol, 276, R357 Vanhorebeek, 2006, Cortisol response to critical illness: effect of intensive insulin therapy, J Clin Endocrinol Metab, 91, 3803, 10.1210/jc.2005-2089 Vermes, 2001, The hypothalamic–pituitary–adrenal response to critical illness, Best Pract Res Clin Endocrinol Metab, 15, 495, 10.1053/beem.2001.0166 Voerman, 1995, Effects of human growth hormone in critically ill nonseptic patients: results from a prospective, randomized, placebo-controlled trial, Crit Care Med, 23, 665, 10.1097/00003246-199504000-00014 Vogel, 1985, Pituitary-testicular axis dysfunction in burned men, J Clin Endocrinol Metab, 60, 658, 10.1210/jcem-60-4-658 Wang, 1978, Effect of acute myocardial infarction on pituitary-testicular function, Clin Endocrinol (Oxf), 9, 249, 10.1111/j.1365-2265.1978.tb02207.x Wang, 1978, Effect of surgical stress on pituitary-testicular function, Clin Endocrinol (Oxf), 9, 255, 10.1111/j.1365-2265.1978.tb02208.x Wartofsky, 1982, Alterations in thyroid function in patients with systemic illness: the “euthyroid sick syndrome”, Endocr Rev, 3, 164, 10.1210/edrv-3-2-164 Weekers, 2002, A novel in vivo rabbit model of hypercatabolic critical illness reveals a biphasic neuroendocrine stress response, Endocrinology, 143, 764, 10.1210/endo.143.3.8664 Weintraub, 1989, Pre-translational and post-translational regulation of TSH synthesis in normal and neoplastic thyrotrophs, Horm Res, 32, 22, 10.1159/000181235 Wigginton, 2010, Rationale for routine and immediate administration of intravenous estrogen for all critically ill and injured patients, Crit Care Med, 38, S620, 10.1097/CCM.0b013e3181f243a9 Woolf, 1985, Transient hypogonadotropic hypogonadism caused by critical illness, J Clin Endocrinol Metab, 60, 444, 10.1210/jcem-60-3-444 Wu, 2004, Upregulation of cardiovascular ghrelin receptor occurs in the hyperdynamic phase of sepsis, Am J Physiol Heart Circ Physiol, 287, H1296, 10.1152/ajpheart.00852.2003 Yen, 2001, Physiological and molecular basis of thyroid hormone action, Physiol Rev, 81, 1097, 10.1152/physrev.2001.81.3.1097 Zellweger, 1996, Prolactin: a novel and safe immunomodulating hormone for the treatment of immunodepression following severe hemorrhage, J Surg Res, 63, 53, 10.1006/jsre.1996.0222 Zellweger, 1998, Metoclopramide: a novel and safe immunomodulating agent for restoring the depressed macrophage immune function after hemorrhage, J Trauma, 44, 70, 10.1097/00005373-199801000-00006 Ziegler, 1990, Use of human growth hormone combined with nutritional support in a critical care unit, JPEN J Parenter Enteral Nutr, 14, 574, 10.1177/0148607190014006574